Plus Therapeutics (PSTV)
(Delayed Data from NSDQ)
$1.69 USD
+0.03 (1.50%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $1.70 +0.01 (0.59%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Cash flow Statements
Fiscal Year End for Plus Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -13.32 | -20.28 | -13.40 | -8.24 | -10.89 |
Depreciation/Amortization & Depletion | 0.82 | 1.01 | 0.94 | 0.95 | 1.45 |
Net Change from Assets/Liabilities | -1.12 | 5.60 | 1.24 | 0.12 | -0.94 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.76 | 0.70 | 0.94 | -1.26 | 4.47 |
Net Cash From Operating Activities | -12.85 | -12.97 | -10.28 | -8.43 | -5.91 |
Property & Equipment | -0.16 | -0.51 | -0.08 | -0.09 | -0.07 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 5.64 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | -0.25 | 0.00 | -0.40 | 0.00 |
Net Cash from Investing Activities | -0.16 | -0.76 | -0.08 | -0.49 | 5.57 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 5.40 | 15.06 | 20.69 | 5.11 | 16.45 |
Issuance (Repayment) of Debt | -1.61 | -1.61 | -0.28 | -5.42 | -3.82 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.35 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 3.45 | 13.45 | 20.42 | -0.32 | 12.63 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -9.57 | -0.28 | 10.05 | -9.25 | 12.29 |
Cash at Beginning of Period | 18.12 | 18.40 | 8.35 | 17.59 | 5.30 |
Cash at End of Period | 8.55 | 18.12 | 18.40 | 8.35 | 17.59 |
Diluted Net EPS | -4.24 | -11.54 | -16.64 | -27.89 | -123.99 |
Fiscal Year End for Plus Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -13.32 | -9.51 | -6.29 | -4.81 |
Depreciation/Amortization & Depletion | NA | 0.82 | 0.64 | 0.44 | 0.22 |
Net Change from Assets/Liabilities | NA | -1.12 | -2.69 | -3.06 | -1.38 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.76 | 0.59 | 0.34 | 0.17 |
Net Cash From Operating Activities | NA | -12.85 | -10.97 | -8.57 | -5.79 |
Property & Equipment | NA | -0.16 | -0.12 | -0.11 | -0.10 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.16 | -0.12 | -0.11 | -0.10 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 5.40 | 5.18 | 2.26 | 0.90 |
Issuance (Repayment) of Debt | NA | -1.61 | -1.21 | -0.80 | -0.40 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.35 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 3.45 | 3.97 | 1.45 | 0.49 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -9.57 | -7.11 | -7.23 | -5.40 |
Cash at Beginning of Period | NA | 18.12 | 18.12 | 18.12 | 18.12 |
Cash at End of Period | NA | 8.55 | 11.01 | 10.90 | 12.72 |
Diluted Net EPS | NA | -0.55 | -1.00 | -0.59 | -2.10 |